Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and histone deacetylase activity.

Source:http://linkedlifedata.com/resource/pubmed/id/21080629

J. Med. Chem. 2010 Dec 23 53 24 8546-55

Download in:

View as

General Info

PMID
21080629